Great West Life Assurance CO Ionis Pharmaceuticals Inc Transaction History

Great West Life Assurance CO

$58 Billion
Q4 2024

A detailed history of Great West Life Assurance CO transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 39,214 shares of IONS stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,214

Previous 39,835 1.56%

Holding current value

$1.29 Million

Previous $1.6 Million 14.44%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$33.73 - $40.36 $20,946 - $25,063	-621 Reduced 1.56%	39,214 $1.37 Million
Q3 2024 Nov 13, 2024	SELL	$40.06 - $51.86 $228,862 - $296,276	-5,713 Reduced 12.54%	39,835 $1.6 Million
Q2 2024 Aug 12, 2024	BUY	$36.45 - $47.7 $133,698 - $174,963	3,668 Added 8.76%	45,548 $2.17 Million
Q1 2024 May 13, 2024	BUY	$42.03 - $53.55 $46,190 - $58,851	1,099 Added 2.69%	41,880 $1.82 Million
Q4 2023 Feb 13, 2024	BUY	$43.39 - $51.63 $172,692 - $205,487	3,980 Added 10.81%	40,781 $2.05 Million
Q3 2023 Nov 14, 2023	BUY	$38.5 - $47.13 $337,183 - $412,764	8,758 Added 31.23%	36,801 $1.67 Million
Q2 2023 Aug 10, 2023	BUY	$34.73 - $43.33 $21,567 - $26,907	621 Added 2.26%	28,043 $1.16 Million
Q1 2023 May 12, 2023	BUY	$33.58 - $41.2 $43,049 - $52,818	1,282 Added 4.9%	27,422 $983,000
Q4 2022 Feb 10, 2023	BUY	$37.12 - $46.52 $334,265 - $418,912	9,005 Added 52.55%	26,140 $993,000
Q3 2022 Nov 01, 2022	BUY	$36.54 - $48.66 $380,564 - $506,793	10,415 Added 154.99%	17,135 $757,000
Q2 2022 Aug 12, 2022	BUY	$31.71 - $43.0 $213,091 - $288,960	6,720 New	6,720 $248,000
Q2 2022 Aug 09, 2022	SELL	$31.71 - $43.0 $209,444 - $284,015	-6,605 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$29.88 - $37.04 $13,087 - $16,223	-438 Reduced 6.22%	6,605 $260,000
Q4 2021 Feb 14, 2022	BUY	$25.61 - $35.1 $3,098 - $4,247	121 Added 1.75%	7,043 $214,000
Q3 2021 Nov 15, 2021	SELL	$33.54 - $40.55 $880,223 - $1.06 Million	-26,244 Reduced 79.13%	6,922 $234,000
Q2 2021 Aug 11, 2021	SELL	$34.54 - $47.25 $839,667 - $1.15 Million	-24,310 Reduced 42.3%	33,166 $1.32 Million
Q1 2021 May 17, 2021	SELL	$42.51 - $63.78 $129,102 - $193,699	-3,037 Reduced 5.02%	57,476 $2.57 Million
Q4 2020 Feb 16, 2021	BUY	$45.3 - $60.27 $381,244 - $507,232	8,416 Added 16.15%	60,513 $3.42 Million
Q3 2020 Nov 17, 2020	BUY	$47.45 - $62.95 $1.25 Million - $1.66 Million	26,363 Added 102.44%	52,097 $2.47 Million
Q3 2020 Nov 13, 2020	SELL	$47.45 - $62.95 $1.15 Million - $1.53 Million	-24,250 Reduced 48.52%	25,734 $1.22 Million
Q2 2020 Aug 17, 2020	BUY	$46.85 - $61.05 $788,954 - $1.03 Million	16,840 Added 50.81%	49,984 $2.94 Million
Q1 2020 May 14, 2020	BUY	$41.6 - $63.4 $7,488 - $11,412	180 Added 0.55%	33,144 $1.58 Million
Q4 2019 Feb 11, 2020	BUY	$53.85 - $65.27 $1.78 Million - $2.15 Million	32,964 New	32,964 $1.99 Million
Q3 2019 Oct 25, 2019	SELL	$59.06 - $72.15 $1.78 Million - $2.18 Million	-30,172 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$62.09 - $86.14 $773,579 - $1.07 Million	12,459 Added 70.34%	30,172 $0
Q1 2019 May 08, 2019	BUY	$52.92 - $81.17 $129,654 - $198,866	2,450 Added 16.05%	17,713 $1.43 Million
Q4 2018 Feb 12, 2019	BUY	$43.37 - $59.54 $66,572 - $91,393	1,535 Added 11.18%	15,263 $796,000
Q2 2018 Aug 10, 2018	SELL	$40.53 - $50.7 $55,728 - $69,712	-1,375 Reduced 9.1%	13,728 $572,000
Q4 2017 Feb 09, 2018	BUY	$50.3 - $64.39 $90,892 - $116,352	1,807 Added 13.59%	15,103 $758,000
Q3 2017 Nov 09, 2017	BUY	$45.56 - $59.57 $605,765 - $792,042	13,296	13,296 $698,000

Others Institutions Holding IONS

# of Institutions

412

Shares Held

140M

Call Options Held

829K

Put Options Held

789K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.68B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Ionis Pharmaceuticals Inc Transaction History